Combined tumor marker used for diagnosis breast cancer and kit thereof
A tumor marker and diagnostic reagent technology, applied in the field of combined tumor markers and their kits, can solve the problems of postoperative recurrence and metastasis affecting survival rate and mortality rate, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Example 1 Experiments on Cells and Breast Cancer Samples
[0042] (1) Experimental process
[0043]Materials and reagents: Fetal bovine serum was purchased from Gibco Company; penicillin-streptomycin for cell culture and TRIzol RNA extraction reagent were purchased from Invitrogen Company; RPMI-1640 and DMEM medium were purchased from Hyclone Company; KOD-plus, RealMasterMix (SYBR Green I) kits, reverse transcription kits were purchased from Dongyangfang Company; restriction endonucleases were purchased from Takara Company; T4DNA ligase, western and IP lysates were purchased from Beyontian Company; large quantities of plasmid extraction kits, plasmid small Quantitative extraction kit, gel recovery kit, and DNA product purification kit were purchased from Tiangen; Protein Inhibitor Cocktail and Phosphotase Inhibitor Cocktail were purchased from Roche Company; nitrocellulose membrane was purchased from Schleicher and Schuell Bioscience Company; goat polyclonal antibody AE...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com